156 related articles for article (PubMed ID: 36741922)
1. Molecular Targets of Shenqi Dihuang, A Traditional Chinese Herbal Medicine, and Its Potential Role in Renal Cell Carcinoma Therapy.
Chen X; Zhang T; Zhan X; Zang X; Zhai X; Wan Z; Ge M; Tan M; Gu J; Xu D
Genet Res (Camb); 2023; 2023():2355891. PubMed ID: 36741922
[TBL] [Abstract][Full Text] [Related]
2. Traditional Chinese medicine Bu-Shen-Jian-Pi-Fang attenuates glycolysis and immune escape in clear cell renal cell carcinoma: results based on network pharmacology.
Zheng J; Xu W; Liu W; Tang H; Lu J; Yu K; Song X; Li F; Wang Y; Wang R; Chen L; Zhang H; Qiu Y; Wei G; Zhou X; Yang J
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34002799
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.
Karim S; Al-Maghrabi JA; Farsi HM; Al-Sayyad AJ; Schulten HJ; Buhmeida A; Mirza Z; Al-Boogmi AA; Ashgan FT; Shabaad MM; NourEldin HF; Al-Ghamdi KB; Abuzenadah A; Chaudhary AG; Al-Qahtani MH
BMC Cancer; 2016 Sep; 16(Suppl 2):741. PubMed ID: 27766950
[TBL] [Abstract][Full Text] [Related]
4. Exploration of the mechanism of Zisheng Shenqi decoction against gout arthritis using network pharmacology.
Li WH; Han JR; Ren PP; Xie Y; Jiang DY
Comput Biol Chem; 2021 Feb; 90():107358. PubMed ID: 33243703
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway.
Liu H; Li X; Duan Y; Xie JB; Piao XL
J Ethnopharmacol; 2021 May; 271():113907. PubMed ID: 33556477
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value.
Zeng Q; Zhang W; Li X; Lai J; Li Z
Life Sci; 2020 Feb; 243():117273. PubMed ID: 31926244
[TBL] [Abstract][Full Text] [Related]
7. A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma.
Xu C; Zeng H; Fan J; Huang W; Yu X; Li S; Wang F; Long X
BMC Cancer; 2022 Mar; 22(1):264. PubMed ID: 35279104
[TBL] [Abstract][Full Text] [Related]
8. Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway.
Wang N; Wang R; Tang J; Gao J; Fang Z; Zhang M; Shen X; Lu L; Chen Y
Contrast Media Mol Imaging; 2022; 2022():5602011. PubMed ID: 36176934
[TBL] [Abstract][Full Text] [Related]
9. Shenqi pill, a traditional Chinese herbal formula, for the treatment of hypertension: A systematic review.
Xiong X; Wang P; Li X; Zhang Y
Complement Ther Med; 2015 Jun; 23(3):484-93. PubMed ID: 26051584
[TBL] [Abstract][Full Text] [Related]
10. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.
Li H
J Ethnopharmacol; 2020 Apr; 251():112442. PubMed ID: 31891799
[TBL] [Abstract][Full Text] [Related]
11. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
[TBL] [Abstract][Full Text] [Related]
12. A Chinese medicine formula Gegen Qinlian decoction suppresses expansion of human renal carcinoma with inhibition of matrix metalloproteinase-2.
Wang N; Feng Y; Cheung F; Wang X; Zhang Z; Feng Y
Integr Cancer Ther; 2015 Jan; 14(1):75-85. PubMed ID: 25228536
[TBL] [Abstract][Full Text] [Related]
13. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H
J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572
[TBL] [Abstract][Full Text] [Related]
14. Restoring the epigenetically silenced PCK2 suppresses renal cell carcinoma progression and increases sensitivity to sunitinib by promoting endoplasmic reticulum stress.
Xiong Z; Yuan C; Shi J; Xiong W; Huang Y; Xiao W; Yang H; Chen K; Zhang X
Theranostics; 2020; 10(25):11444-11461. PubMed ID: 33052225
[No Abstract] [Full Text] [Related]
15. MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
Schanza LM; Seles M; Stotz M; Fosselteder J; Hutterer GC; Pichler M; Stiegelbauer V
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165391
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma: resistance to therapy, role of apoptosis, and the prognostic and therapeutic target potential of TRAF proteins.
Rajandram R; Bennett NC; Morais C; Johnson DW; Gobe GC
Med Hypotheses; 2012 Feb; 78(2):330-6. PubMed ID: 22153576
[TBL] [Abstract][Full Text] [Related]
17. Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma.
Wang C; Li Y; Chu CM; Zhang XM; Ma J; Huang H; Wang YN; Hong TY; Zhang J; Pan XW; Zheng JC; Jiang N; Hu CY; Ma X; Sun YH; Cui XG
EBioMedicine; 2019 Jan; 39():255-264. PubMed ID: 30558998
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
19. The potential of Lycium barbarum miR166a in kidney cancer treatment.
Zhang Q; Xie Z; Li Y; Zhu Q; Shi H; Zhao R; Yang X; Tian J; Ma L
Exp Cell Res; 2023 Feb; 423(1):113455. PubMed ID: 36584744
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
